ERBB2 and breast cancer: Breast cancer brain metastases (BCBM) occur more frequently in patients with HER2-positive breast cancer and TNBC; these two sub-types exhibit a 2 to 5-fold increased risk of developing BCBM when compared to HR-positive cancers5–7.